Open access · CC-BY
via OpenAlex
Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury
Dong Liu, Liqun Xu, Xiaoyan Zhang, Changhong Shi, Shubin Qiao, Zhiqiang Ma, Jiansong Yuan
Aging and Disease · 2018 · ▲ 32 citations
Abstract
Aging may aggravate the damage and dysfunction of different components of multiorgan and thus increasing multiorgan ischemia/reperfusion (IR) injury. IR injury occurs in many organs and tissues, which is a major cause of morbidity and mortality worldwide. The kinase mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR), an atypical serine/threonine protein kinase, involves in the pathophysiological process of IR injury. In this review, we first briefly introduce the molecular features of mTOR, the association between mTOR and aging, and especially its role on autophagy(definition). Special focus is placed on the roles of mTOR during ischemic and IR injury. We then clarify the association between mTOR and conditioning phenomena. Following this background, we expand our discussion to potential future directions of research in this area. Collectively, information reviewed herein will serve as a comprehensive reference for the actions of mTOR in IR injury and may be significant for the design of future research and increase the potential of mTOR as a therapeutic target.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.14336/ad.2018.0501
- Canonical
- link ↗
- Fetched
- 2026-06-27 MST
Cite this
APA
Liu, D., Xu, L., Zhang, X., Shi, C., Qiao, S., Ma, Z., & Yuan, J. (2018). Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury. <em>Aging and Disease</em>. https://doi.org/10.14336/ad.2018.0501
Vancouver
Liu D, Xu L, Zhang X, Shi C, Qiao S, Ma Z, et al. Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury. Aging and Disease. 2018. doi:10.14336/ad.2018.0501.
BibTeX
@article{dong2018Snapsh,
title = {Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury},
author = {Dong Liu and Liqun Xu and Xiaoyan Zhang and Changhong Shi and Shubin Qiao and Zhiqiang Ma and Jiansong Yuan},
journal = {Aging and Disease},
year = {2018},
doi = {10.14336/ad.2018.0501},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Endocrinology 2022
Open access · CC-BY
Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1
Biochemistry (Moscow) 2019
Citation only
Rapamycin Is Not Protective against Ischemic and Cisplatin-Induced Kidney Injury
Oncotarget 2016
Open access · CC-BY
Towards understanding the lifespan extension by reduced insulin signaling: bioinformatics analysis of DAF-16/FOXO direct targets in <i>Caenorhabditis elegans</i>
Cureus 2025
Open access · OA
The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity.
Antioxidants 2021
Open access · CC-BY
Flavonoids’ Effects on Caenorhabditis elegans’ Longevity, Fat Accumulation, Stress Resistance and Gene Modulation Involve mTOR, SKN-1 and DAF-16
European Heart Journal 2015
Open access · OA